Featured Research

from universities, journals, and other organizations

Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Date:
April 5, 1999
Source:
University Of California, San Francisco
Summary:
UC San Francisco researchers have determined how a protein already strongly associated with colon cancer actually exacts its toll, offering a potential new target for drug therapy.

UC San Francisco researchers have determined how a protein already strongly associated with colon cancer actually exacts its toll, offering a potential new target for drug therapy.

In their study, published in the April 1 issue of Nature, the investigators report that a protein known as beta catenin gives colon cells the internal nudge they need to circumvent a molecular checkpoint that normally regulates the cycle of cell growth. By evading the checkpoint, known as retinoblastoma (Rb), colon cells proceed to divide uncontrollably and excessively, a hallmark of cancer.

"We've known for several years that colon cancers have high levels of this protein, and that it almost certainly drives the cancer," said the senior author of the study, Frank McCormick, Ph.D., F.R.S., director of the UCSF Cancer Research Institute. "The question has been, `how the heck it does it.'"

A conundrum for researchers has been the fact the retinoblastoma checkpoint remains intact in colon cancer cells.

"Probably every human cancer has a defect in the retinoblastoma checkpoint, and it is this defect that allows cells to grow under conditions that would be forbidden in normal cells," said McCormick. "In colon cancer, it's been known for years that the checkpoint is intact. We've determined that colon cancers have found a way around the checkpoint."

McCormick and Osamu Tetsu, M.D., Ph.D., a visiting postdoctoral fellow in McCormick's lab, determined that beta catenin disrupts cell regulation by synthesizing cyclin D1, a protein that prompts cells to enter S-phase, the point at which a cell duplicates its DNA, in preparation for cell division. "High levels of cyclin D1 override the checkpoint," said McCormick. "This explains how the cells proliferate out of control even though the checkpoint remains intact."

The finding, said McCormick, should fuel ongoing efforts by pharmaceutical companies to develop ways to block beta catenin, which plays a direct causal role in the development of most colon cancers, and a number of other cancers as well, including melanoma, gastric cancer, prostate cancer and hepatocellular carcinoma, said McCormick.

It has been known for years that a mutation in a tumor-suppressor gene known as adenomatous polyposis coli (APC) occurs in the majority of human colon cancers, and several years ago researchers discovered that the mutated gene leads to the activation of the beta catenin protein.

"Now we have identified at least one consequence of APC mutation," said McCormick. "We can now test the contribution that this makes to the initiation and progression of the disease. This should help us assess the potential of therapies based on our discovery."


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy." ScienceDaily. ScienceDaily, 5 April 1999. <www.sciencedaily.com/releases/1999/04/990405065906.htm>.
University Of California, San Francisco. (1999, April 5). Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1999/04/990405065906.htm
University Of California, San Francisco. "Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy." ScienceDaily. www.sciencedaily.com/releases/1999/04/990405065906.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins